0 min read
Science
Related posts
Generation of Antibodies to Difficult Membrane Protein Targets
Multipass transmembrane and multimeric membrane proteins are targets for the development of therapeutic monoclonal antibodies, but they present challenges for antibody generation.
Capturing the Functional Antibody Repertoire from Multiple B-cell Subsets Following Antigen Stimulation
Discover the power of B-cells as the ultimate antibody source with Cellestive. Unlock diverse antibody repertoires seamlessly and cost-effectively.
Influence of Adjuvants on the Quantity, Affinity, Isotype and Epitope Specificity of Murine Antibodies
Five adjuvants were compared to Freund's adjuvant for production of mouse polyclonal antibodies and monoclonal antibodies (McAbs) to human serum albumin (HSA) and interleukin-1 alpha (IL-1 alpha).
Optimization of Therapeutic Discovery Strategies for Human Antibody Transgenic Animal Platforms
Immunization of transgenic animals producing human antibodies has been the most successful approach to obtaining fully human therapeutic antibodies.
AET2025 - Antibody Solutions Poster
Discover how Antibody Solutions' Cellestive™ platform efficiently interrogates various B-cell types to generate diverse, unique antibodies for therapeutic applications. Download our latest research poster.
Generation of Agonist and Antagonist Human Monoclonal Antibodies Against an Immune Checkpoint Target from the H2L2 Mouse
Immunization of transgenic animals producing human antibodies is by far the most successful approach to obtaining “fully human” therapeutic antibodies.
